BeStock  
Stocks › Biotechnology › KYMR

Kymera Therapeutics KYMR

US equityMarket cap rank #1426Biotechnology
$115.31 −$4.08 (-3.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $124.06 +7.59%
Open$117.89
Prev close$119.39
Day range$114.40 – $119.60
Volume1.28M
Market cap$9.84B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$150.69+30.7% vs. price
  • Buy 100%
Low $129.00Now $115.31Avg $150.69High $180.00

Recent rating changes

The last 20 actions on file set price targets from $129.00 to $180.00, averaging $149.40.

DateFirmRatingTarget
3 Nov 2026 CCORF BUY $129.00
2 Nov 2026 Barclays BUY $170.00
1 Nov 2026 BTIG BUY $139.00
30 Oct 2026 CCORF BUY $129.00
30 Oct 2026 Morgan Stanley BUY $150.00
30 Oct 2026 Barclays BUY $170.00
29 Oct 2026 Wells Fargo BUY $151.00
29 Oct 2026 Raymond James BUY $144.00
29 Oct 2026 BTIG BUY $139.00
29 Oct 2026 Citi BUY $150.00
28 Oct 2026 Guggenheim BUY $170.00
15 Oct 2026 Wells Fargo BUY $151.00
15 Oct 2026 Citi BUY $150.00
8 Oct 2026 Raymond James BUY $140.00
5 Oct 2026 Citi BUY $150.00
28 Sep 2026 J.P. Morgan BUY $140.00
23 Sep 2026 Piper Sandler BUY $140.00
22 Sep 2026 Stifel BUY $152.00
14 Sep 2026 BofA Securities BUY $144.00
10 Sep 2026 Wolfe Research BUY $180.00

Discussion

No comments yet — be the first to weigh in on KYMR.

Sign in to join the discussion.

Scroll to Top